Discovery of IL-18 as a novel secreted protein contributing to doxorubicin resistance by comparative secretome analysis of MCF-7 and MCF-7/Dox.
BACKGROUND: Resistance to chemotherapy is the major cause of failure in breast cancer treatment. Recent studies suggest that secreted proteins may play important roles in chemoresistance. We sought to systematically characterize secreted proteins associated with drug resistance, which may represent...
Main Authors: | Ling Yao, Yan Zhang, Keying Chen, Xiaofang Hu, Lisa X Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3169632?pdf=render |
Similar Items
-
Brazilein Increased Cytotoxic Activity of Doxorubicin on MCF-7/DOX Cells
by: Ni Putu Linda Laksmiani, et al.
Published: (2015-06-01) -
Effects of silencing Ki-67 gene on doxorubicin resistance of breast cancer MCF-7/DOX cells
by: DONG Jun, CUI Fengming, LIU Jun
Published: (2023-05-01) -
Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells
by: Xu Wang, et al.
Published: (2019-12-01) -
PROFIL MicroRNA 451 (miR451) DAN P-GLYCOPROTEIN (PGP) PADA CELL LINE MCF-7 RESISTEN DOXORUBICIN (MCF-7/DOX)
by: , Fuad Gandhi Torizal, et al.
Published: (2013) -
Corrigendum: Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells
by: Xu Wang, et al.
Published: (2020-11-01)